我院静脉药物配置中心2012年9月-2014年2月抗肿瘤药不合理医嘱分析

发布时间：2018-03-18 14:17

本文选题：静脉药物配置中心　切入点：抗肿瘤药　出处：《中国药房》2015年02期 　论文类型：期刊论文

【摘要】：目的:为降低临床抗肿瘤药不合理用药发生率提供参考。方法:调取我院静脉药物配置中心超然管理系统中2012年9月-2014年2月抗肿瘤药医嘱,对不合理医嘱进行分析和总结。结果:在审核的51 204条医嘱中,不合理用药为201条,占0.39%;不合理用药主要表现在溶剂选择不当(42.79%)、给药剂量过大或过小(17.91%)、溶剂体积不合理(32.33%)、给药途径错误(3.98%)、给药顺序不合理(2.49%)以及其他方面(0.50%),医嘱修改率分别为97.67%、100%、95.38%、100%、80.00%及100%。结论:通过定期分析、总结,以医师联系单的形式及不合理医嘱的汇总形式与病房沟通,可以加强对抗肿瘤药应用的监督,保障患者用药安全。
[Abstract]:Objective: to provide a reference for reducing the incidence of irrational use of antitumor drugs. Methods: from September 2012 to February 2014, the antitumor doctors' orders were obtained from the transcendental management system of the intravenous Drug allocation Center in our hospital. Analysis and summary of unreasonable medical orders. Results: of the 51,204 medical orders examined, 201 were irrational drug use. The irrational use of drugs was mainly manifested in improper choice of solvent (42.79), excessive or too small dose of medicine (17.91U), unreasonable volume of solvent (32.331U), wrong way of administration (3.98b), irrational order of administration (2.49th) and other aspects. The revised rate of doctor's orders was 97.67100%, 95.38%, 80.00% and 100000, respectively. Conclusion: through regular analysis, In conclusion, to communicate with the ward in the form of doctor contact list and unreasonable doctor's advice can strengthen the supervision of the application of antitumor drugs and ensure the safety of drug use by patients.
【作者单位】：重庆医科大学附属第一医院药学部;
【分类号】：R95

【相似文献】